Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 4/2017

Open Access 01-08-2017 | Case Report

Two cases of serious rhabdomyolysis during linezolid treatment

Authors: Arno M. Lechner, Eva Past, Ulla Porsche, Jan M. Kern, Uta Hoppe, Ingrid Pretsch

Published in: Infection | Issue 4/2017

Login to get access

Abstract

Linezolid is an oxazolidinone antibiotic with activity against gram-positive organisms, particularly methicillin-resistant Staphylococcus aureus (MRSA). To the best of our knowledge, there are only two case reports on rhabdomyolysis in patients treated with linezolid. Here, we describe two cases of serious rhabdomyolysis: one in a patient with septic community-acquired (CA)-MRSA pneumonia and a second case in a patient with suspected catheter-related blood stream infection.
Literature
1.
Fomda BA, Thokar MA, Khan A, Bhat JA, Zahoor D, Bashir G, Majid A, Ray P. Nasal carriage of methicillin-resistant Staphylococcus aureus among healthy population of Kashmir, India. Indian J Med Microbiol. 2014;32:39–41.CrossRefPubMed
2.
Sazdanovic P, Jankovic SM, Kostic M, Dimitijevic A, Stefanovic S. Pharmacokinetics of linezolid in critically ill patients. Expert Opin Drug Metab Toxicol. 2016;12:595–600.CrossRefPubMed
3.
4.
Wunderink RG. How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy? Infect Dis Clin North Am. 2013;27:177–88.CrossRefPubMed
5.
Boselli E, Breilh D, Rimmelé T, Djabarouti S, Toutain J, Chassard D, Saux MC, Allaouchiche B. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia. Crit Care Med. 2005;33(7):1529–33.CrossRefPubMed
6.
7.
Shorr AF, Kunkel MJ, Kollef M. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2005;56:923–9.CrossRefPubMed
8.
9.
Allison GW, Perla RJ, Belliveau PP, Angelis SM. Elevated creatine phosphokinase levels associated with linezolid therapy. Am J Health Syst Pharm. 2009;66:1097–100.CrossRefPubMed
10.
Carroll MW, Choi H, Min S, Hwang S, Park H, Song T, Park Y, Jeon HS, Goldfeder LC, Via LE, Lebron J, Jin B, Cai Y, Barry CE 3rd, Lee M. Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis. Clin Infect Dis. 2012;54:1624–7.CrossRefPubMedPubMedCentral
11.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.CrossRefPubMed
Metadata
Title
Two cases of serious rhabdomyolysis during linezolid treatment
Authors
Arno M. Lechner
Eva Past
Ulla Porsche
Jan M. Kern
Uta Hoppe
Ingrid Pretsch
Publication date
01-08-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0978-8

Other articles of this Issue 4/2017

Infection 4/2017 Go to the issue

Original Paper

Deficits in knowledge, attitude, and practice towards blood culture sampling: results of a nationwide mixed-methods study among inpatient care physicians in Germany

Images in Infection

Multiple molluscum contagiosum lesions in adults suggesting compromised immune system

Case Report

Septic arthritis due to Legionella cincinnatiensis: case report and review of the literature

Original Paper

Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

Original Paper

Pulmonary mucormycosis: clinical features and outcomes

Original Paper

Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogens

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits